Galera Therapeutics' GAAP loss for 6M 2021 was $41.101 million, up 10.9% from $37.074 million in the prior year.
Galera Therapeutics' GAAP loss for 6M 2021 was $41.101 million, up 10.9% from $37.074 million in the prior year.
Financial results
Galera Therapeutics' GAAP loss for 6M 2021 was $41.101 million, up 10.9% from $37.074 million in the prior year. Source: 
investors.galeratx.com
investors.galeratx.com News feed
English (US) 